Vista Investment Partners LLC Has $297,000 Position in UnitedHealth Group Incorporated $UNH

Vista Investment Partners LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 24.6% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 951 shares of the healthcare conglomerate’s stock after selling 311 shares during the quarter. Vista Investment Partners LLC’s holdings in UnitedHealth Group were worth $297,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of UNH. Brighton Jones LLC grew its position in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC lifted its stake in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares in the last quarter. Two Sigma Advisers LP bought a new stake in UnitedHealth Group in the 4th quarter valued at approximately $14,063,000. Woodline Partners LP bought a new stake in UnitedHealth Group in the 4th quarter valued at approximately $26,637,000. Finally, Waverly Advisors LLC raised its stake in shares of UnitedHealth Group by 69.8% during the 4th quarter. Waverly Advisors LLC now owns 20,522 shares of the healthcare conglomerate’s stock worth $10,381,000 after purchasing an additional 8,433 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

UNH stock opened at $341.46 on Thursday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market cap of $309.25 billion, a PE ratio of 14.79, a P/E/G ratio of 2.22 and a beta of 0.45. The firm has a 50 day simple moving average of $294.30 and a two-hundred day simple moving average of $367.06.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Analyst Ratings Changes

A number of research firms recently weighed in on UNH. Oppenheimer decreased their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. HSBC reissued a “reduce” rating and set a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Robert W. Baird restated an “underperform” rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Bank of America upped their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research report on Monday, August 18th. Finally, Sanford C. Bernstein increased their target price on UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.